Delayed recovery of hypertension after single dose losartan in angiotensin II-infused conscious rats

Journal of Hypertension

Volumn 17, Issue 10, 1999, Pages 1443-1450

  Hu, Lufei ^a   Catanzaro, Daniel F ^a   Laragh, John H ^a   Sealey, Jean E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II infusion; Angiotensin II receptor antagonism; Blood pressure; Heart rate; Losartan; Plasma renin; Rat

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032710626     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917100-00012     Document Type: Article

References (24)

1. Laragh JH Sealey JE. The renin-angiotensin-aldosterone system and the renal regulation of sodium and potassium and blood pressure homeostasis. In: Windhager EE (editor): Handbook of renal physiology. New York: Oxford University Press; 1992. pp. 1409-1541.
2. Dickinson CJ, Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ Res 1967; 20/21 (suppl II):II157-II163.
3. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol 1991; 261:H1284-H1291.
4. Cowley AW, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ Res 1976; 39:779-787.
5. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH. Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin invest 1965; 44:1171-1186.
6. Lever AF, Lyall F, Morton JJ, Folkow B. Angiotensin II, vascular structure and blood pressure. Kidney Int 1992; 41:S51-S55.
7. Hu L, Catanzaro DF, Pitarresi TM, Laragh JH, Sealey JE. Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats. J Hypertens 1998; 16:1285-1298.
8. Simon G Abraham G. Angiotensin II administration as an experimental model of hypertension. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995. pp. 1423-1435.
9. Young DB, Murray RH, Bongis RG, Markov AK. Experimental angiotensin II hypertension. Am J Physiol 1980; 239:H391-H398.
10. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and non neural components, time cause, and dose dependency. Am J Physiol 1996; 271:R200-R207.
11. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986; 250:R960-R972.
12. Reid IA. Interactions between Ang II, sympathetic nervous system, and barorecepter reflexes in regulation of blood pressure. Am J Physiol 1992; 262:E763-E778.
13. Fink GD, Bruner CA, Mangiapane ML, Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987; 9:355-361.
14. Folkow B, Lever AF. Does the rapidity with which hypertension reverses on unclipping a clipped kidney and on stopping long-term infusion of angiotensin II make unlikely an important role for vascular hypetrophy in maintaining the hypertension seen before reversal [letter]. J Hum Hyp 1995; 9:487-488.
15. Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II pressor effects. J Pharmacol Exp Ther 1994; 271:804-810.
16. Waeber B, Brunner HR, Brunner DB, Curtet A, Turini GA, Gavras H. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension 1980; 2:236-242.
17. van den Meiracker AH, Admirall PJJ, Man in 't Veld AJ, Derkx FHM, Ritsema van Eck HJ, Mulder P, et al. Prolonged blood pressure reduction by orally active renin inhibitor RO42-5892 in essential hypertension. Br Med J 1990; 301:205-210.
18. Vaur L, Bobrie G, Dutrey-Dupagne C, Dubroca I, Vaisse B, Bouvier d'Yvoire M, et al. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients. Am J Hypertens 1998; 11:165-173.
19. Campbell WG Jr, Gahnem F, Catanzaro DF, James GD, Camargo MJF, Laragh JH, Sealey JE. Plasma and renal prorenin/renin, renin mRNA and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension 1996; 27:1121-1133.
20. Dunnett CW. New tables for multiple comparisons with a control. Biometrics 1964; 20:482-491.
21. Hu L, Catanzaro DF, Laragh JH, Sealey JE. No effect of beta-blockade on the secondary heart rate-related increase in blood pressure caused by Ang II infusions in conscious rats [abstract]. Am J Hypertens 1999; 14A:12.
22. Rosenthal J, Swales JD, Dzau VJ. Vascular renin and hypertension. J Hypertens 1987; 5 (suppl II):S1-S78.
23. Lutterotti NV, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues: a review of experimental evidence. Circulation 1994; 89:458-470.
24. Zimmerman BG, Dunham EW. Tissue renin-angiotensin system: a site of drug action? Ann Rev Pharmacol Toxicol 1997; 37:53-69.